The advent of ultrasound recording has expanded the capabilities for treatment of the fetus in utero. The diagnosis of specific disease processes has allowed for prenatal intervention by new techniques designed to improve fetal survival. The application of ventricular pacing in a hydropic fetus with complete atrioventricular (AV) block is reported. Complete AV block resulted from maternal collagen vascular disease. The application of ventricular pacing was to allow for further in utero development and for reversal of hydrops fetalis after improvement in cardiac output. Despite fetal death 4 hours Complete atrioventricular (A V) block is usually well tolerated in utero during the third trimester unless the ventricular rate is extremely slow or associated cardiac defects result in AV valve regurgitation. Nonimmunologic hydrops fetalis may result (1,2), which represents severe fetal cardiac decompensation due to congestive heart failure. The hydropic fetus with complete AV block will die in utero if left untreated in almost all cases. At present, a viable hydropic fetus with complete AV block is delivered by cesarean section, and temporary ventricular pacing is initiated during perinatal resuscitation (3). However, even after this course, perinatal mortality exceeds 80% (3,4). Because the prognosis for the hydropic fetus is poor, we have applied a
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Ventricular pacing was accomplished without apparent trauma to mother or fetus and no evidence of fetal injury was seen at necropsy. Therefore, in the fetus who would otherwise die in utero before the point of viability ex utero, fetal ventricular pacing may be a rational alternative to current observation.
( Fetal echocardiography. Two-dimensional echocardiographic evaluation (Acuson-128) revealed complete AV block with an atrial rate of 128/min and a ventricular rate of 32/min. A 3 mm pericardial effusion had developed. The left ventricular shortening fraction was 47% with an internal diastolic diameter of 10 mm. The right atrial wall was hypertrophied and the right ventricle was markedly enlarged (16 mm end-diastolic dimension), using the criteria of DeVore et al. (5) . No structlJral defect was present. Pulsed Doppler sampling (ATL 6(0) in the right and left atria at the level of the AV valves revealed mild tricuspid and mitral insufficiency.
Fetal pacing procedures. Informed consent for transuterine transthoracic fetal ventricular pacing was obtained after extensive discussions with the physicians involved and a presentation to the parents of all known risks and potential benefits as well as an explanation of the uncertainties.
The mother was not sedated for the procedure. Xylocaine, I%, was infiltrated subcutaneously in the maternal abdomen . The fetus remained quiet in a left occiput posterior position. Under continuous sector scanning, a 17 gauge Tuohy needle was inserted into the uterine cavity and was advanced into the fetal thorax and into the right ventricle (Fig . I) . Removal of the obturator yielded pulsatile blood flow. Although considered , no attempt was made to obtain cardiac blood for arterial blood gases or digoxin level determinations .
An Electro-Catheter Corporation model II-KPJl bipolar pigtail pacing catheter previously removed from an adult Pace-lector ™ insertion device was sheathed within a 19 g epidural catheter, which had been shortened to allow easy passage of the pacing wire through its lumen . The pacing apparatus was threaded into the fetal right ventricle and the pigtail pacing wire advanced out of the sheath . The sheath and needle were removed , avoiding tension on the slack wire . The pacing wire was secured with suture to the maternal abdomen.
The pacing wire was attached to a Medtronic exernal pulse generator and ventricular pacing was initiated at a rate of 120/min . Ultrasound examination revealed ventricular contractions at 120/min . The pacemaker output was decreased until ventricular noncapture was apparent with return to a ventricular rate of 32. The ventricular capture threshold was 1.5 rnA. The pacemaker was programmed to 6 rnA ventricular output with a rate of 120 beats/min.
Course. The mother was sedated and placed at bed rest. External Doppler fetal heart tone monitoring revealed a heart rate of 120 beats/min. Four hours and 15 minutes after initiation of fetal pacing , intermittent irregular heart tones were noted . The pacemaker output was increased to 20 rnA. Ventricular capture did not impro ve and within 5 minute s fetal heart sounds were no longer evident. Ultrasound examination revealed fetal asystole . The pacing catheter had not changed position and remained in the right ventricle . There was no hematoma in the ventricular wall and no thrombi within the ventricles. No change in the pericardial effusion was evident. The pacing catheter was removed and labor induced .
Fetal autopsy. At postmortem examination, the heart was anatomically normal with right atrial and ventricular enlargement. The entry site in the right ventricle could not be identified. A serosanguinous pericardial effusion was present. Immunofluorescent studies were performed using labeled antibodies to human immunoglobulins G and A and C3 complement. Deposition of these three proteins was present in both ventricles. December 19X 6:1434-6 
Discussion
The applicatio n of transuterine-transtho racic fetal pacing for co mplete AV block has not been previou sly reported as a method of treatment for severe fetal bradyarrh ythmia. Complete A V block may be a major cause of intrauterine fetal death in women with collagen vascular disease in whom the incidence of unexplained fetal death may exceed 10 percent (6 ). Litsey et al. (7) reported positiv e immun ofluore scent studies of fetal atrial tissue which identified SSA (anti-Ro) antib odie s and interruption of the spec ia lized myocardial conduction fibers in the fetus . Identi cal findings were see n in our pat ient.
Medical management.
There has been no adequate prenatal treatment for hydrops related to fetal bradycardia . When hydrops devel ops , the ventricular rate is usually less than 50 beats/m in. Becau se this degre e of bradycardia probably repre sents an idioventric ular escape rhythm, it is unlikely that atro pine wo uld be effec tive . Ca techolamines and betaadrenergic stimulants may be tried but terbu taline and isoprot erenol were not effe ctive in this patient.
.
Goals of fetal pacing.
The goa l of fetal transth oracic ventricular pacing was to provide temp orary acce leration of the fetal ventricular rate. In the absence of AV valve regurgitation , this should have impro ved cardiac output~nd allowed right atrial pressure to return to normal. Had pacing been effective in maintain ing fetal life , digoxin wou ld have been used to improve stroke volume and a diuretic agent used to enh ance resolution of edema.
Limitations of fetal pacing. Fetal tran sthoracic pacing has seve ral limitations. Th e present pacing lead is only moderately flexible and could becom e dislodged or cause inj ury with vigo rous fetal movem ent. Fetal mo vement s are minimal in severe hydrops, but fetal activity should increase with resolution of con gestive heart failure . A longer lead with greater flexibility is required if prolonged temp orary or impl antable fetal pacemakers are to be de veloped. Th e external pacing system requires maternal bed rest and presents a risk of bacteri al chorioa rnnionitis. Delivery of the fetus would require cesarean section to prevent dislodgment of the pacing ca theter dur ing deli very . The lead would need to be transected and pacing temp orarily stopped durin g delivery . Th e placent a and fetus must be located in the uteru s in positions that allow access to the heart . It is not known whether incre asing ventric ular rate rapidly with fetal pacing result s in any metaboli c or acid-base imbalances as a consequ ence of increasing myocardial ox ygen con sumption and cardiac output. In our patient, a slower acceleration of fetal cardiac rate might have prevented an adv erse outcome .
Application of fetal pacing. Several factors appe ar favora ble for future application of intrauterine pacing . The initial ventric ular pacing thre shold was extremel y low in this hydropic fetus. If applicable to other fetuses , this would potentially allow the use of impl antable fetal pacemakers . Sedation docs not appear necess ary to maintain inactivity of the hydropi c fetus during placement of the pacing lead .
No matern al o r fetal morbidity could be directly attributed to insert ion of the pacin g lead . The bipolar pacing lead did not induc e uter ine contractions. Th is technique requ ires the ex pertise of a team co mposed of a perin atologist, ultrasonographer and pediatric e lectrophysiologist. It should not be applied in the nonh ydropic fetus unless physiologic data sugges ting ea rly co nges tive heart failure develop . Because the hydropi c fetus is at such high risk for death in utero or if delivered , fetal pac ing may be viewe d as a reasonable extreme therapy. Th e development of a research pro gram utilizing an anim al model would be optimal before the application of this technique on a routine basis in the hum an fetus. Ob stetrical contrai ndications should not be ignored in an attempt to save a hydropic fetus. However, despite these limitations, fetal pacing should be considere d for the treatment of the dying fetus with complete AV block.
